PLOD1 and ovarian hyperstimulation syndrome: The hormone used to provide this LH-like exposure plays a determinant role in key outcomes affecting the success and safety of IVF treatment, including the ability to retrieve mature oocytes, luteal phase characteristics (impacting on pregnancy rates) and the occurrence of “ovarian hyperstimulation syndrome” (OHSS) (2).